Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer

NCT01962324 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
85
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Umeå University